EBR Systems Inc (EBR) is a company dedicated to treatment of cardiac rhythm disease by providing physiologically effective stimulation through cardiac pacing. The Company's patented Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for cardiac pacing leads, historically the source of complications and reliability issues in cardiac rhythm management.
Big bowl formation that's broken topside. FDA approval last week, being a fundamental piece of information, will drive price towards a $1.80 target, though probably not in 8 weeks. Just wish I had seen this one on a break of the 70c range
